IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 34 filers reported holding IMPEL NEUROPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,053 | -62.4% | 172,218 | +11.1% | 0.00% | – |
| Q2 2023 | $196,799 | -9.0% | 154,960 | +0.4% | 0.00% | – |
| Q1 2023 | $216,146 | +37295.5% | 154,390 | +0.1% | 0.00% | – |
| Q4 2022 | $578 | -99.9% | 154,238 | +3.8% | 0.00% | – |
| Q3 2022 | $723,000 | -32.6% | 148,646 | +29.0% | 0.00% | – |
| Q2 2022 | $1,073,000 | +4.2% | 115,185 | -28.8% | 0.00% | – |
| Q1 2022 | $1,030,000 | -7.3% | 161,789 | +25.6% | 0.00% | – |
| Q4 2021 | $1,111,000 | -22.6% | 128,800 | +9.2% | 0.00% | – |
| Q3 2021 | $1,436,000 | +219.1% | 117,916 | +131.5% | 0.00% | – |
| Q2 2021 | $450,000 | – | 50,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NVP Associates, LLC | 3,077,198 | $1,323,195 | 1.18% |
| 5AM Venture Management, LLC | 2,884,791 | $1,240,460 | 0.36% |
| venBio Partners LLC | 2,759,791 | $1,186,710 | 0.34% |
| Vivo Capital, LLC | 2,884,789 | $1,240,459 | 0.14% |
| LASRY MARC | 225,874 | $97,126 | 0.10% |
| Kohlberg Kravis Roberts & Co. L.P. | 4,135,971 | $1,778,468 | 0.06% |
| DCF Advisers, LLC | 178,500 | $76,755 | 0.04% |
| EPIQ PARTNERS, LLC | 16,325 | $7,020 | 0.01% |
| MCDONALD PARTNERS LLC | 19,400 | $8,342 | 0.00% |
| XTX Topco Ltd | 21,222 | $9,125 | 0.00% |